May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Expression of Matrix Metalloproteinases & Their Inhibitors Is Closely Related to the Proliferation of Differentiation in Retinoblastoma
Author Affiliations & Notes
  • C. Cho
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • Y. Yu
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • H. Jun
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • D. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • K. Kim
    Ophthalmology, Seoul National University, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  C. Cho, None; J. Kim, None; J. Kim, None; Y. Yu, None; H. Jun, None; D. Kim, None; K. Kim, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 20. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Cho, J. Kim, J. Kim, Y. Yu, H. Jun, D. Kim, K. Kim; The Expression of Matrix Metalloproteinases & Their Inhibitors Is Closely Related to the Proliferation of Differentiation in Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2008;49(13):20. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the expression of matrix metalloproteinase (MMP)-2,-9,-14 and tissue inhibitor of metalloproteinase (TIMP)-1,-2 in retinoblastoma and to elucidate their roles in the proliferation or differentiation of retinoblastoma cells

Methods: : Y79, SNUOT-Rb1 or-Rb4 retinoblastoma cells were injected into the intravitreal cavity of nude mice, and enucleation was performed 4weeks later. Immunohistochemistry for MMP-2, 9, 14 and TIMP-1, 2 was performed, which were merged with Ki67, nm23 or TUNEL. With treatment of retinoic acid or bFGF, MMP-2, 9, 14 and TIMP-1, 2 expression in retinoblastoma cells were mesured by western blotting. The effect of a MMP inhibitor on the differentiation or proliferation was evaluated as well.

Results: : In animal model of retinoblastoma with Y79, SNUOT-RB1, and Rb-4, MMP-2 &-9 were highly expressed in the proliferative area of retinoblastoma, whereas MMP-14 expression was prominent in the differentiated area. With the proliferation of retinoblastoma cells, MMP-2 & -9 expression was increased which were inhibited by a MMP inhibitor. However, with the differentiation of retinoblastoma cells, MMP-14 expression was increased.

Conclusions: : Our data suggest that differential expression of MMP-2,-9, or -14 may be a related to proliferation or differentiation of retinoblastoma cells. In addition, MMP inhibitor could be applied as a treatment agent for retinoblastoma.

Keywords: retinoblastoma • immunohistochemistry • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×